Cancer Biomarkers in Diagnosis and Therapeutics

Dr. Adeeb Shehzad is currently serving as Assistant Professor in the Department of Biomedical Engineering and Sciences at School of Mechanical and Manufacturing Engineering, National University Sciences and Technology, Islamabad, Pakistan and editorial board member of journal Pancreatic Disorders and Therapy. He completed his MS (2008-2010) and Ph.D (2010-2014) from School of Life Sciences at Kyungpook National University, Daegu, South Korea. He has earlier served as a Research Professor in the School of Life Sciences at Kyungpook National University, Daegu, South Korea (2014-2015) and Visiting Professor at Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman bin Faisal University (IAU), Dammam, Saudi Arabia (2019-2021). His research interest is mainly oriented to the screening and development of plant isolated compounds as anticancer agents, as well as the in-vitro and in-vivo studies of synthetic drugs on modulation of different signaling pathways in cancers. He has been conferred with various scholarships notably, Kyungpook Honor Scholarship and Higher Education Commission awards for MS and PhD studies. He is also serving as a referee for a well-known research journals, including Cancer Research (UK), Molecules and Cells (South Korea), BBA Molecular Cell Research (UK) and MDPI journals. He has more than 10 years of teaching experience in Cancer Biology, Pharmacology and Biotechnology. He has also published more than 70 research articles in the peer-reviewed international journal and authored or co-authored numerous book chapters. He is a member of many international scientific societies and organizations importantly, Korean Society of Molecular and Cellular Biology, South Korea, honorary member of Drug Regulatory Authority of Pakistan (DRAP) and Pakistan Pharmacist Association, Pakistan.    

​Chapter 1. Introduction to cancer biomarkers.- Chapter 2.Technologies for identification and validation of cancer biomarkers.- Chapter 3. BIOMARKERS FOR CANCER DRUG DEVELOPMENT.- Chapter 4. Clinical proteomics: diagnostics and prognostic markers of Cancer.- Chapter 5.Microbiome as cancer biomarkers.- Chapter 6. Predictive biomarkers for anticancer drugs.- Chapter 7. Biomarkers in Cancer Survival and Drug Resistance.- Chapter 8. Biomarkers in tumor recurrence and metastasis.- Chapter 9. Biomarkers for Cancer Immunotherapy.- Chapter 10. Role of Biomarkers in Personalized Medicine.- Chapter 11.Development of Novel Cancer Biomarkers for Diagnosis and Prognosis.- Chapter 12. Nanotechnology for Cancer Biomarkers.